HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $276,115 | +4.0% | 3,165 | 0.0% | 0.00% | – |
| Q2 2023 | $265,480 | -73.7% | 3,165 | -74.1% | 0.00% | -100.0% |
| Q1 2023 | $1,009,302 | +34.9% | 12,197 | +28.3% | 0.00% | +100.0% |
| Q4 2022 | $747,962 | +202.8% | 9,510 | +185.4% | 0.00% | – |
| Q3 2022 | $247,000 | +8.3% | 3,332 | -4.7% | 0.00% | – |
| Q2 2022 | $228,000 | +9.1% | 3,498 | +18.2% | 0.00% | – |
| Q3 2021 | $209,000 | -60.6% | 2,959 | -50.0% | 0.00% | -100.0% |
| Q2 2020 | $530,000 | -15.1% | 5,922 | -5.4% | 0.00% | -50.0% |
| Q1 2020 | $624,000 | -1.3% | 6,262 | +13.9% | 0.00% | 0.0% |
| Q4 2019 | $632,000 | -78.9% | 5,500 | -76.9% | 0.00% | -75.0% |
| Q3 2019 | $3,001,000 | +6.8% | 23,793 | +1.9% | 0.01% | +14.3% |
| Q2 2019 | $2,810,000 | -71.9% | 23,350 | -79.6% | 0.01% | -70.8% |
| Q1 2019 | $10,014,000 | -49.0% | 114,475 | -41.7% | 0.02% | -53.8% |
| Q4 2018 | $19,632,000 | -2.1% | 196,225 | +12.1% | 0.05% | +6.1% |
| Q3 2018 | $20,057,000 | +81.2% | 175,050 | +41.8% | 0.05% | +75.0% |
| Q2 2018 | $11,069,000 | +420.9% | 123,430 | +140.1% | 0.03% | +180.0% |
| Q2 2013 | $2,125,000 | – | 51,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |